Sort
23,748 grants matching “melanoma”
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
$712,871Daniel B Stetson · University Of Washington · R01 · FY2025 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,800Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2021 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,800Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2023 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,799Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2025 · CA
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$712,799Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2024 · CA
Studies of Receptor Interactions and Effects of Alarmins
$712,775Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$712,726Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer
$711,990Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2025 · CA
Uses of GEM models for Translational Cancer Research
$711,971Lynda Chin · University Of Tx Md Anderson Can Ctr · U01 · FY2013 · CA
MOLECULAR PATHWAYS OF UVEAL MELANOMA DORMANCY
$711,821Dana-Farber Cancer Institute, Inc. · · FY2025 · Defense Health Agency
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA
$711,704Aadel Chaudhuri · Mayo Clinic Rochester · R01 · FY2024 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$711,323Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$711,004Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Quantifying patient-provider communication using machine learning to assess its impact on metastatic cancer patients' outcomes
$710,264Samah Jamal Fodeh Jarad · Yale University · R01 · FY2024 · CA
A Systems Biology Approach for Pediatric and Adult Autoimmune Diseases
$710,160Maria Virginia Pascual · Baylor Research Institute · U19 · FY2012 · AI
Identifying modifiable factors that reduce the burden of late stage melanoma in Hispanics
$710,139Myles G Cockburn · University Of Southern California · R01 · FY2024 · CA
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$709,818Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2014 · CA
Neoadjuvant SEMA4D/ICB therapy for melanoma
$709,554Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Biology and genetics of metastatic disease
$709,351Sohail F. Tavazoie · Rockefeller University · R35 · FY2022 · CA
Inhibition of p53 Tumor Suppressor Function by HTLV-I
$709,332John N. Brady · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Yale SPORE in Skin Cancer
$709,079Ruth Halaban · Yale University · P50 · FY2017 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$708,555Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Multi-cellular interactions defining the human brain metastatic niche
$708,550Benjamin Izar · Columbia University Health Sciences · R01 · FY2023 · CA
Product for sensitive imaging of cells in vivo
$707,370Brooke Helfer · Celsense, Inc. · R44 · FY2020 · EB
Noninvasive prediction of skin precancer severity using in vivo cellular imaging and deep learning algorithms.
$707,350Gabriel Nestor Sanchez · Enspectra Health, Inc. · R44 · FY2024 · CA